...

FDA Cleared

Advancing Skin Cancer Detection: American Academy of Dermatology Journal Publishes DermaSensor’s Breakthrough Melanoma Detection Results from A Major, Multicenter Trial

MIAMI, February 28, 2024 (BUSINESSWIRE)— DermaSensor Inc., a health technology company equipping physicians with a non-invasive device for use in the evaluation of suspicious skin lesions, announces the publication of strong results from a multi-center, prospective device validation study for melanoma detection. The study, titled “DERMaSensor Use in the ASSESSment of Skin Lesions Suggestive of […]

DermaSensor Announces Senior Medical and Commercial Hires Upon Receiving FDA Clearance of its First-In-Class Device

MIAMI, FLORIDA, USA, January 31, 2024, [EINPresswire.com] — DermaSensor Inc., which recently announced FDA clearance of the first-of-its-kind, FDA Breakthrough handheld device that uses artificial intelligence to non-invasively detect the three most common types of skin cancer (Melanoma, BCC, and SCC), enlists new team members to strengthen their commitment to broaden access to effective evaluation of suspicious […]

FDA Clearance Granted for First AI-Powered Medical Device to Detect All Three Common Skin Cancers (Melanoma, Basal Cell Carcinoma and Squamous Cell Carcinoma)

MIAMI–(BUSINESS WIRE)–DermaSensor Inc. announces FDA clearance for its real-time, non-invasive skin cancer evaluation system. For the first time, the 300,000 primary care physicians in the U.S. can now be equipped to provide quantitative, point-of-care testing for all types of skin cancer. Better identifying skin cancer in a primary care setting is designed to accelerate patient access […]

FDA Breakthrough Device using Optical Spectroscopy was Found to Significantly Increase Physicians’ Detection of Skin Cancer

MIAMI, Florida, December 13, 2023 (BusinessWire)  DermaSensor Inc., the pioneer of the first point-and-click skin cancer detection device for primary care physicians, announces the publication of a new study1 in the Journal of Primary Care and Community Health. This study, authored by medical leaders including Laura Korb Ferris, MD, and Todd Thames, MD, evaluated the […]

New Study of an AI-Powered Spectroscopy Device Shows Promise for Skin Cancer Detection

MIAMI–(BUSINESS WIRE)–DermaSensor Inc. – Skin cancer is a global health concern, with increasing incidence rates worldwide. Artificial Intelligence (AI) is expanding its presence within dermatology with several tools available abroad, although no skin cancer AI imaging tools are currently available in the U.S. that are approved by the FDA. A newly published study was designed to evaluate […]

DermaSensor Bolsters Leadership Team And Commercial Advisory Board

Health Technology Executives Steve Meyer, ex-Pres/CEO of Welch Allyn, and Jason Bellet, Co-Founder/Board Member of Eko Health, join Commercial Advisory Board MIAMI, September 25, 2023, EINPresswire.com — a leader in the field of non-invasive skin cancer detection technology, announced the latest hires to its leadership team and commercial advisory board as it continues its mission […]

DermaSensor Study Results For Skin Cancer Detection Device Performance Across Skin Tones Of Over 1,000 Patients

Presented at the 2023 American Academy of Dermatology Innovation Academy, the findings demonstrate the potential for DermaSensor’s device to help detect skin cancer across a range of skin types MIAMI, August 10, 2023, Business Wire — DermaSensor Inc., a health technology company equipping primary care physicians (PCPs) with a non-invasive device for evaluating suspicious skin […]

DermaSensor Presents Study Results on Melanoma Detection in a Medicare Population at American Dermoscopy Meeting

DermaSensor’s Device with FDA Breakthrough Designation Demonstrated 96.2% Sensitivity for Detecting Melanoma in Patients Aged 65 and Older MIAMI, July 13, 2023, Business Wire — DermaSensor Inc., a health technology company equipping primary care physicians (PCPs) with a non-invasive device for use in evaluation of suspicious skin lesions, presented to the 11th Annual American Dermoscopy […]

DermaSensor’s Non-Invasive Skin Cancer Device Found to Halve the Number of Skin Cancers Not Referred by PCPs

Presented at the Society of Teachers of Family Medicine (STFM) 2023 annual meeting, the two FDA pivotal studies validated the performance and benefit of the hand-held, non-invasive, optical spectroscopy device in point-of-care skin lesion evaluation. MIAMI, May 04,2023, Business Wire — DermaSensor Inc., in collaboration with leading medical institutions such as Mayo Clinic and the […]

Newsroom

DermaSensor’s Non-Invasive Skin Cancer Device Found to Halve the Number of Skin Cancers Not Referred by PCPs